Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Kidney Transplantation

Free Subscription Articles published in Kidney Int Retrieve available abstracts of 130 articles: HTML format

Single Articles

April 2024
1. CORNELL LD, Shankaranarayanan D, Rodriguez PS, Damgard SE, et al
   Sickle cell disease in the kidney transplant.
   Kidney Int. 2024;105:892.
   PubMed    
   
   
   
2. LEVIN A, Ahmed SB, Carrero JJ, Foster B, et al
   Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
   Kidney Int. 2024;105:684-701.
   PubMed     Abstract available
   
   
   
3. CALLEMEYN J, Naesens M
   Back to the future: the uncharted role of T cells in chronic and unexplained microvascular inflammation.
   Kidney Int. 2024;105:669-671.
   PubMed     Abstract available
   
   
   
4. CRISTOFERI I, Varol H, van Baardwijk M, Rahiem L, et al
   Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass.
   Kidney Int. 2024;105:812-823.
   PubMed     Abstract available
   
   
   March 2024
5. MA BM, Elefant N, Tedesco M, Bogyo K, et al
   Genetic testing in kidney transplantation helped develop a morbidity gene panel for evaluation of kidney transplant recipients.
   Kidney Int. 2024 Mar 21:S0085-2538(24)00188-1. doi: 10.1016/j.kint.2024.
   PubMed     Abstract available
   
   
   
6. JARMI T, Luo Y, Attieh RM, Qie Y, et al
   CAR T-cell therapy-paving the way for sensitized kidney transplant patients.
   Kidney Int. 2024 Mar 21:S0085-2538(24)00159-5. doi: 10.1016/j.kint.2024.
   PubMed    
   
   
   
7. PALMER ND, Freedman BI
   APOL1-mediated and Mendelian forms of "heretofore" idiopathic collapsing glomerulopathy: lessons from Brazil.
   Kidney Int. 2024;105:437-439.
   PubMed     Abstract available
   
   
   
8. RAINA R, Jothi S, Haffner D, Somers M, et al
   Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
   Kidney Int. 2024;105:450-463.
   PubMed     Abstract available
   
   
   
9. SHIRAI Y, Miura K, Ishizuka K, Ando T, et al
   A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence.
   Kidney Int. 2024;105:608-617.
   PubMed     Abstract available
   
   
   
10. GILL JS, Chadban SJ
    Pretransplant screening for coronary artery disease: data are required before practice change.
    Kidney Int. 2024;105:470-472.
    PubMed     Abstract available
    
    
    February 2024
11. VENKATARAMAN K, McTaggart SJ, Collins MG
    Choosing fluids to reduce the risks of acute electrolyte disturbances in children after a kidney transplant.
    Kidney Int. 2024;105:247-250.
    PubMed     Abstract available
    
    
    
12. HAAS M
    Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence.
    Kidney Int. 2024;105:240-242.
    PubMed     Abstract available
    
    
    
13. SHAH Y, Yang H, Mueller FB, Li C, et al
    Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Kidney Int. 2024;105:347-363.
    PubMed     Abstract available
    
    
    
14. LOBAN K, Fadel E, Nugus P, Przybylak-Brouillard A, et al
    Living kidney donors' health care needs, experiences, and perspectives across their entire donation trajectory: a semistructured, in-depth interview study.
    Kidney Int. 2024;105:251-258.
    PubMed    
    
    
    
15. YI Z, Xi C, Menon MC, Cravedi P, et al
    A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization.
    Kidney Int. 2024;105:281-292.
    PubMed     Abstract available
    
    
    January 2024
16. LUO X, Knechtle S
    The T-cell environment: may the regulatory force be with you.
    Kidney Int. 2024;105:20-22.
    PubMed     Abstract available
    
    
    October 2023
17. HAYES WN, Laing E, Brown R, Silsby L, et al
    A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
    Kidney Int. 2023 Oct 30:S0085-2538(23)00760-3. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
18. BUDDE K, Rostaing L
    A first small step toward personalized immunosuppression.
    Kidney Int. 2023;104:652-654.
    PubMed     Abstract available
    
    
    
19. BAILLY E, Macedo C, Ossart J, Louis K, et al
    Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56(dim)CD16(bright) natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
    Kidney Int. 2023;104:707-723.
    PubMed     Abstract available
    
    
    September 2023
20. VON SAMSON-HIMMELSTJERNA FA, Kolbrink B, Schulte K
    Relative excess mortality risk after kidney transplantation: Eve's loss or Adam's win?
    Kidney Int. 2023;104:619-620.
    PubMed    
    
    
    
21. SARWAL MM, Naesens M
    Urine trumps the protocol biopsy for subclinical rejection surveillance.
    Kidney Int. 2023;104:432-439.
    PubMed    
    
    
    
22. NAKAMURA Y, Inoue T
    Tolerogenic dendritic cells: promising cell therapy for acute kidney injury.
    Kidney Int. 2023;104:420-422.
    PubMed     Abstract available
    
    
    August 2023
23. STEHLE T, Letavernier E, Joher N, Mesnard L, et al
    Tolvaptan to prevent calcium oxalate crystal deposition in the kidney allograft after kidney transplantation for primary hyperoxaluria.
    Kidney Int. 2023;104:398.
    PubMed    
    
    
    
24. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.
    PubMed    
    
    
    July 2023
25. METRY EL, Deesker LJ, Garrelfs SF, Oosterveld MJS, et al
    Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy.
    Kidney Int. 2023;104:203-204.
    PubMed    
    
    
    
26. TANTISATTAMO E, Kalantar-Zadeh K
    PRECEDE/PROCEED framework for public health program planning in preparation for current and future unprecedented events for patients with kidney failure and living with a kidney transplant.
    Kidney Int. 2023;104:202-203.
    PubMed    
    
    
    June 2023
27. LLOBERAS N, Grinyo JM, Colom H, Vidal-Alabro A, et al
    A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
    Kidney Int. 2023 Jun 28:S0085-2538(23)00475-1. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
28. DE FIJTER JW, Dreyer GJ, Mallat MJ, Budde K, et al
    A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
    Kidney Int. 2023 Jun 19:S0085-2538(23)00419-2. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
29. ISNARD P, Tang E, Mroue A, Letavernier E, et al
    The Case | Crescentic glomerulonephritis in a kidney transplant recipient.
    Kidney Int. 2023;103:1205-1206.
    PubMed    
    
    
    
30. JEHN U, Kohler M, Reuter S
    An unusual case of ascites after kidney transplantation.
    Kidney Int. 2023;103:1203.
    PubMed    
    
    
    
31. TRUCHOT A, Raynaud M, Loupy A
    Excess mortality after kidney transplantation: does sex matter?
    Kidney Int. 2023;103:1023-1024.
    PubMed     Abstract available
    
    
    
32. MCDANIELS JM, Shetty AC, Kuscu C, Kuscu C, et al
    Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis.
    Kidney Int. 2023;103:1077-1092.
    PubMed     Abstract available
    
    
    May 2023
33. BEADLE J, Papadaki A, Toulza F, Santos E, et al
    Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection.
    Kidney Int. 2023 May 10:S0085-2538(23)00331-9. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
34. GANDOLFINI I, Alibrandi S, Gentile M, Russo LS, et al
    Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation.
    Kidney Int. 2023;103:995-996.
    PubMed    
    
    
    
35. SCHOLD JD
    The promise and reality of machine-learning models in kidney transplantation.
    Kidney Int. 2023;103:835-836.
    PubMed     Abstract available
    
    
    
36. TRUCHOT A, Raynaud M, Kamar N, Naesens M, et al
    Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction.
    Kidney Int. 2023;103:936-948.
    PubMed     Abstract available
    
    
    April 2023
37. BANJONGJIT A, Wuttiputhanun T, Vanichanan J, Ueaphongsukkit T, et al
    The Case | Hematuria and hypercalcemia in a kidney transplant recipient.
    Kidney Int. 2023;103:801-802.
    PubMed    
    
    
    
38. RHEE EP
    Kidney-specific metabolomic profiling in machine perfusate.
    Kidney Int. 2023;103:661-663.
    PubMed     Abstract available
    
    
    
39. BASU S, Dorling A, Chong AS
    A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection.
    Kidney Int. 2023;103:658-660.
    PubMed     Abstract available
    
    
    
40. LIU RX, Koyawala N, Thiessen-Philbrook HR, Doshi MD, et al
    Untargeted metabolomics of perfusate and their association with hypothermic machine perfusion and allograft failure.
    Kidney Int. 2023;103:762-771.
    PubMed     Abstract available
    
    
    March 2023
41. DANGER R, Le Berre L, Cadoux M, Kerleau C, et al
    Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00186-2. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    February 2023
42. VINSON A, Zhang X, Dahhou M, Susal C, et al
    A multinational cohort study uncovered sex differences in excess mortality after kidney transplant.
    Kidney Int. 2023 Feb 17:S0085-2538(23)00083-2. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
43. JOHNSON RJ, Warady BA
    Does kidney transplant improve health-related quality of life for youth with chronic kidney disease?
    Kidney Int. 2023;103:256-258.
    PubMed     Abstract available
    
    
    January 2023
44. SAPIR-PICHHADZE R, Oertelt-Prigione S
    P3(2): A Sex- and Gender-Sensitive Model for Evidence-Based Precision Medicine - from Knowledge Generation to Implementation in the Field of Kidney Transplantation.
    Kidney Int. 2023 Jan 30:S0085-2538(23)00053-4. doi: 10.1016/j.kint.2022.
    PubMed     Abstract available
    
    
    November 2022
45. CHERUKURI A, Abou-Daya KI, Chowdhury R, Mehta RB, et al
    Transitional B cell Cytokines Risk Stratify Early Borderline Rejection After Renal Transplantation.
    Kidney Int. 2022 Nov 24:S0085-2538(22)00969-3. doi: 10.1016/j.kint.2022.
    PubMed     Abstract available
    
    
    
46. MEINDERTS JR, Schreuder MF, de Jong MFC
    Pregnancy after kidney transplantation: more attention is needed for long-term follow-up of the offspring.
    Kidney Int. 2022;102:1190-1191.
    PubMed    
    
    
    
47. HAAS M, Mirocha J, Huang E, Najjar R, et al
    A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
    Kidney Int. 2022 Nov 1. pii: S0085-2538(22)00912.
    PubMed     Abstract available
    
    
    October 2022
48. GUHA C, van Zwieten A, Khalid R, Kim S, et al
    Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease.
    Kidney Int. 2022 Oct 28. pii: S0085-2538(22)00906.
    PubMed     Abstract available
    
    
    
49. MOREAU A, Kervella D, Bouchet-Delbos L, Braudeau C, et al
    A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
    Kidney Int. 2022 Oct 25. pii: S0085-2538(22)00845.
    PubMed     Abstract available
    
    
    
50. JESUDASON S, Piccoli GB
    Pregnancy outcomes after kidney transplantation: the challenges of success.
    Kidney Int. 2022;102:697-699.
    PubMed     Abstract available
    
    
    September 2022
51. ROSEN RJ, Prakash-Polet S, Liu P, Batal I, et al
    The Case | An unusual cause of proteinuria in a kidney transplant recipient.
    Kidney Int. 2022;102:673-674.
    PubMed    
    
    
    
52. KIBERD BA, Lim WH
    The windows of opportunity.
    Kidney Int. 2022;102:479-481.
    PubMed     Abstract available
    
    
    
53. GIARRATANO Y, Pugh D, Farrah TE, Oniscu GC, et al
    Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.
    Kidney Int. 2022;102:661-665.
    PubMed    
    
    
    August 2022
54. BENOTMANE I, Velay A, Vargas GG, Olagne J, et al
    A rapid decline in the anti-receptor binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
    Kidney Int. 2022 Aug 13. pii: S0085-2538(22)00616.
    PubMed    
    
    
    
55. CACHO J, Nicolas D, Bodro M, Cuadrado-Payan E, et al
    USE OF REMDESIVIR IN KIDNEY TRANSPLANT RECIPIENTS WITH SARS-COV-2 OMICRON INFECTION.
    Kidney Int. 2022 Aug 11. pii: S0085-2538(22)00613.
    PubMed    
    
    
    
56. BOU SABA J, Cherukuri A
    Antigen-specific B cells in kidney transplantation.
    Kidney Int. 2022;102:233-235.
    PubMed     Abstract available
    
    
    July 2022
57. KAMINSKI H, Gigan M, Vermorel A, Charrier M, et al
    Covid-19 morbidity decreases with Tixagevimab/cilgavimab preexposure prophylaxis in kidney transplant recipients non/low vaccine responders.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00550.
    PubMed    
    
    
    
58. MANOHARAN K, Gupta P, Mehta H, Nada R, et al
    The Case | Inflammatory polyarthritis in a kidney transplant recipient.
    Kidney Int. 2022;102:215-216.
    PubMed    
    
    
    
59. JAMHOUR-CHELH K, Melendo-Viu M, Dobarro D, Raposeiras-Roubin S, et al
    Acute heart failure in a kidney transplant patient.
    Kidney Int. 2022;102:211.
    PubMed    
    
    
    
60. VAN LOON E, Lamarthee B, de Loor H, Van Craenenbroeck AH, et al
    Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology.
    Kidney Int. 2022;102:183-195.
    PubMed     Abstract available
    
    
    June 2022
61. GOSSELINK ME, van Buren MC, Kooiman J, Groen H, et al
    A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes.
    Kidney Int. 2022 Jun 28. pii: S0085-2538(22)00468.
    PubMed     Abstract available
    
    
    
62. SCHOLD JD, Huml AM, Poggio ED, Reese PP, et al
    A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States.
    Kidney Int. 2022 Jun 24. pii: S0085-2538(22)00462.
    PubMed     Abstract available
    
    
    
63. ANDERSON B, Qasim M, Evison F, Gallier S, et al
    A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation.
    Kidney Int. 2022 Jun 15. pii: S0085-2538(22)00450.
    PubMed     Abstract available
    
    
    
64. VAN DER WEIJDEN J, Mahesh SVK, van Londen M, Bakker SJL, et al
    Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function.
    Kidney Int. 2022;101:1251-1259.
    PubMed     Abstract available
    
    
    May 2022
65. SURI RS, Lee JY, Ban MR, Shrum B, et al
    Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans.
    Kidney Int. 2022 May 27. pii: S0085-2538(22)00381.
    PubMed    
    
    
    
66. MONTAGUD-MARRAHI E, Cuadrado-Payan E, Hermida E, Cacho J, et al
    Preemptive simultaneous pancreas kidney transplantation has survival benefit to patient.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00385.
    PubMed     Abstract available
    
    
    
67. BERTRAND D, Laurent C, Lemee V, Lebourg L, et al
    Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients.
    Kidney Int. 2022 May 23. pii: S0085-2538(22)00382.
    PubMed    
    
    
    
68. BASU S, Dorling A
    Regulation of T- and B-cell interactions determines the clinical phenotype associated with donor-specific antibodies.
    Kidney Int. 2022;101:877-879.
    PubMed     Abstract available
    
    
    April 2022
69. BURTON H, McLaughlin L, Shiu KY, Shaw O, et al
    The phenotype of HLA-binding B-cells from sensitized kidney transplant recipients correlates with clinically prognostic patterns of interferon-gamma production against purified HLA proteins.
    Kidney Int. 2022 Apr 25. pii: S0085-2538(22)00339.
    PubMed     Abstract available
    
    
    
70. AL JURDI A, Gassen RB, Borges TJ, Lape IT, et al
    Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
    Kidney Int. 2022 Apr 13. pii: S0085-2538(22)00288.
    PubMed    
    
    
    
71. CHAVAROT N, Melenotte C, Amrouche L, Rouzaud C, et al
    Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection.
    Kidney Int. 2022 Apr 11. pii: S0085-2538(22)00272.
    PubMed    
    
    
    
72. HUANG E, Jordan SC
    Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitations.
    Kidney Int. 2022;101:676-677.
    PubMed     Abstract available
    
    
    
73. LASSEN E, Daehn IS
    Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation.
    Kidney Int. 2022;101:673-676.
    PubMed     Abstract available
    
    
    
74. LOGEL SN, Connor EL, Paloian NJ
    The Case | A 17-year-old boy with growth failure and chronic kidney disease.
    Kidney Int. 2022;101:837-838.
    PubMed    
    
    
    March 2022
75. PERKINS GB, Tunbridge M, Salehi T, Chai CS, et al
    Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.
    Kidney Int. 2022 Mar 15. pii: S0085-2538(22)00172.
    PubMed    
    
    
    
76. SUWELACK B, Berger K, Wolters H, Gerss JWO, et al
    Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation.
    Kidney Int. 2022;101:597-606.
    PubMed     Abstract available
    
    
    February 2022
77. BENOTMANE I, Bruel T, Planas D, Fafi-Kremer S, et al
    A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients.
    Kidney Int. 2022 Feb 26. pii: S0085-2538(22)00168.
    PubMed    
    
    
    
78. MASSET C, Benotmane I, Dantal J, Garandeau C, et al
    A fourth SARS-Cov-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00093.
    PubMed    
    
    
    
79. ERPICUM P, Grosch S, Bonvoisin C, Bouquegneau A, et al
    The Case | An unusual cause of renal vascular thrombi after kidney transplantation.
    Kidney Int. 2022;101:427-428.
    PubMed    
    
    
    January 2022
80. LOUIS K, Fadakar P, Macedo C, Yamada M, et al
    Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation.
    Kidney Int. 2022 Jan 25. pii: S0085-2538(22)00027.
    PubMed     Abstract available
    
    
    
81. DUCLOUX D, Courivaud C
    REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01216.
    PubMed    
    
    
    
82. JEFFERIS J, Kassianos AJ, Grivei A, Doucet B, et al
    SARS-CoV-2 vaccination-associated collapsing glomerulopathy in a kidney transplant recipient.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01219.
    PubMed    
    
    
    
83. SALEM F, Perin L, Sedrakyan S, Angeletti A, et al
    The spatially resolved transcriptional profile of acute T cell-mediated rejection in a kidney allograft.
    Kidney Int. 2022;101:131-136.
    PubMed     Abstract available
    
    
    December 2021
84. BENNING L, Morath C, Bartenschlager M, Reineke M, et al
    Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared to two-dose BNT162b2 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Dec 23. pii: S0085-2538(21)01169.
    PubMed    
    
    
    
85. SUGIANTO RI, Memaran N, Schmidt BMW, Doyon A, et al
    Insights from the 4C-T Study suggest increased cardiovascular burden in girls with end stage kidney disease before and after kidney transplantation.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01163.
    PubMed     Abstract available
    
    
    
86. MENON R, Otto EA, Berthier CC, Nair V, et al
    Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01162.
    PubMed     Abstract available
    
    
    
87. LOUPY A, Mengel M, Haas M
    30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics.
    Kidney Int. 2021 Dec 16. pii: S0085-2538(21)01142.
    PubMed     Abstract available
    
    
    
88. CALLEMEYN J, Lamarthee B, Koenig A, Koshy P, et al
    Allorecognition and the spectrum of kidney transplant rejection.
    Kidney Int. 2021 Dec 13. pii: S0085-2538(21)01143.
    PubMed     Abstract available
    
    
    
89. MASSET C, Ville S, Garandeau C, Le Borgne F, et al
    Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.
    Kidney Int. 2021 Dec 8. pii: S0085-2538(21)01136.
    PubMed    
    
    
    
90. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
    Kidney Int. 2021;100:1348-1349.
    PubMed    
    
    
    November 2021
91. ASHCROFT J, Leighton P, Elliott TR, Hosgood SA, et al
    Extracellular Vesicles in Kidney Transplantation: A State of the Art Review.
    Kidney Int. 2021 Nov 25. pii: S0085-2538(21)01082.
    PubMed     Abstract available
    
    
    October 2021
92. YI Z, Salem F, Menon MC, Keung K, et al
    Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.
    Kidney Int. 2021 Oct 29. pii: S0085-2538(21)01025.
    PubMed     Abstract available
    
    
    
93. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T cell response to a third dose of SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00924.
    PubMed    
    
    
    
94. DUCLOUX D, Courivaud C
    Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
    Kidney Int. 2021;100:939-940.
    PubMed    
    
    
    
95. LEFAUCHEUR C, Louis K, Philippe A, Loupy A, et al
    The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyond.
    Kidney Int. 2021;100:787-798.
    PubMed     Abstract available
    
    
    September 2021
96. PEDERSEN RM, Bang LL, Tornby DS, Kierkegaard H, et al
    The SARS-CoV-2-neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine.
    Kidney Int. 2021 Sep 20. pii: S0085-2538(21)00866.
    PubMed    
    
    
    
97. WESTHOFF TH, Seibert FS, Anft M, Blazquez-Navarro A, et al
    A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral non-response.
    Kidney Int. 2021 Sep 9. pii: S0085-2538(21)00850.
    PubMed    
    
    
    
98. AZZI Y, Raees H, Wang T, Cleare L, et al
    Risks factors associated with poor response to COVID-19 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Sep 2. pii: S0085-2538(21)00826.
    PubMed    
    
    
    August 2021
99. DE GREEF J, Devresse A, Albichr IS, Scohy A, et al
    Better Late than Never: Eventual Seroconversion against SARS-CoV-2 in a Kidney Transplant Recipient after Repeated Immune Challenge and Monoclonal Antibody Therapy.
    Kidney Int. 2021 Aug 31. pii: S0085-2538(21)00825.
    PubMed    
    
    
    
100. MASSET C, Kerleau C, Garandeau C, Ville S, et al
     A third injection of BNT162b2 mRNA Covid-19 vaccine in kidney transplant recipients improves the humoral immune response.
     Kidney Int. 2021 Aug 30. pii: S0085-2538(21)00809.
     PubMed    
     
     
     
101. CHAVAROT N, Parize P, Podglajen I, Sberro-Soussan R, et al
     The Case | Cardiac tamponade in a kidney transplant recipient with chronic inflammation.
     Kidney Int. 2021;100:487-488.
     PubMed    
     
     
     
102. MENGEL M, Lubetzky M
     Do we need to treat chronic active T cell-mediated rejection?
     Kidney Int. 2021;100:275-277.
     PubMed     Abstract available
     
     
     
103. CAILLARD S, Chavarot N, Bertrand D, Kamar N, et al
     Occurrence of severe COVID-19 in vaccinated transplant patients.
     Kidney Int. 2021;100:477-479.
     PubMed    
     
     
     
104. ARYKBAEVA AS, de Vries DK, Doppenberg JB, Engelse MA, et al
     Metabolic needs of the kidney graft undergoing normothermic machine perfusion.
     Kidney Int. 2021;100:301-310.
     PubMed     Abstract available
     
     
     
105. KUNG VL, Sandhu R, Haas M, Huang E, et al
     Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.
     Kidney Int. 2021;100:391-400.
     PubMed     Abstract available
     
     
     
106. SENEV A, Van Loon E, Lerut E, Callemeyn J, et al
     Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
     Kidney Int. 2021;100:401-414.
     PubMed     Abstract available
     
     
     July 2021
107. TAMBUR AR, Kosmoliaptsis V, Claas FH, Mannon RB, et al
     Significance of HLA-DQ in kidney transplantation - Time to re-evaluate HLA matching priorities to improve transplant outcomes? An expert review and recommendations.
     Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00657.
     PubMed     Abstract available
     
     
     
108. DALOUL R, Pesavento T, Goldberg DS, Reese PP, et al
     A Review of kidney transplantation from HCV-Viremic Donors into Negative Recipients.
     Kidney Int. 2021 Jul 5. pii: S0085-2538(21)00669.
     PubMed     Abstract available
     
     
     
109. MADHAVAN SM
     APOL1 genotyping in kidney transplantation: a look into the future.
     Kidney Int. 2021;100:32-34.
     PubMed    
     
     
     
110. KUMAR V, Locke JE
     APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
     Kidney Int. 2021;100:30-32.
     PubMed    
     
     
     
111. FREEDMAN BI, Poggio ED
     APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
     Kidney Int. 2021;100:27-30.
     PubMed    
     
     
     
112. YAMADA M, Iwamoto H, Konno O, Kihara Y, et al
     Pelvic arteriovenous malformation in a kidney transplant recipient.
     Kidney Int. 2021;100:246.
     PubMed    
     
     
     
113. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
     Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
     Kidney Int. 2021;100:243.
     PubMed    
     
     
     June 2021
114. IKIZLER TA, Coates PT, Rovin BH, Ronco P, et al
     Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
     Kidney Int. 2021;99:1275-1279.
     PubMed     Abstract available
     
     
     
115. RAMSPEK CL, El Moumni M, Wali E, Heemskerk MBA, et al
     Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation.
     Kidney Int. 2021;99:1459-1469.
     PubMed     Abstract available
     
     
     May 2021
116. DOLFF S, Baotong Z, Korth J, De L, et al
     Evidence of Cell Mediated Immune response in kidney transplants with negative mRNA-1273 Antibody Response.
     Kidney Int. 2021 May 21. pii: S0085-2538(21)00511.
     PubMed    
     
     
     
117. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
     Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
     Kidney Int. 2021;99:1245.
     PubMed    
     
     
     
118. LIANG EN W, Tan CS, Conceicao EP, Venkatachalam I, et al
     Zero health care-associated respiratory viral infections: impact of enhanced infection prevention on a renal unit during the coronavirus disease 2019 pandemic.
     Kidney Int. 2021;99:1236-1238.
     PubMed    
     
     
     
119. SOTOMAYOR CG, Groothof D, Vodegel JJ, Eisenga MF, et al
     Plasma cadmium is associated with increased risk of long-term kidney graft failure.
     Kidney Int. 2021;99:1213-1224.
     PubMed     Abstract available
     
     
     
120. DUJARDIN A, Lorent M, Foucher Y, Legendre C, et al
     Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death.
     Kidney Int. 2021;99:1189-1201.
     PubMed     Abstract available
     
     
     April 2021
121. CHANG CC, Vlad G, Vasilescu ER, Husain SA, et al
     Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
     Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00457.
     PubMed    
     
     
     
122. PUTTARAJAPPA CM, Jorgensen D, Yabes JG, Jeong K, et al
     Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.
     Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00460.
     PubMed     Abstract available
     
     
     
123. DEL BELLO A, Marion O, Delas A, Congy-Jolivet N, et al
     Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient.
     Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00466.
     PubMed    
     
     
     
124. CLAUDIO P, Rosaria CM
     The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation.
     Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00454.
     PubMed     Abstract available
     
     
     
125. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
     Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine.
     Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00389.
     PubMed    
     
     
     
126. COOREY CP, Sharma A, Muller S, Yang JYH, et al
     Prediction modeling-part 2: using machine learning strategies to improve transplantation outcomes.
     Kidney Int. 2021;99:817-823.
     PubMed     Abstract available
     
     
     November 2020
127. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
     Candida crescents in a renal allograft.
     Kidney Int. 2020;98:1356.
     PubMed    
     
     
     May 2020
128. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
     Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
     Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
     PubMed     Abstract available
     
     
     January 2020
129. SIGOGNE M, Culty T, Meria P, Demiselle J, et al
     Encrusted pyelitis in a kidney allograft.
     Kidney Int. 2020;97:217.
     PubMed    
     
     
     
130. PERAZELLA MA, Shirali AC
     Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?
     Kidney Int. 2020;97:62-74.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge.